連礞湯灌腸治療痰瘀交阻型室性早搏的臨床觀察
[Abstract]:Objective: to observe the clinical efficacy and safety of Professor Guo Wenqin, a famous Chinese medicine professor, in the treatment of phlegm and blood stasis type ventricular premature beat (PVCs) by using Chinese medicine theory. To explore the feasibility and application value of LianMengtang enema in TCM. Methods: sixty patients with ventricular premature beats of phlegm and blood stasis type were randomly divided into two groups. There was no significant difference between the two groups in age, duration of disease, sex and so on. There were 30 cases in mesiglitazone oral group and 30 cases in LianMengtang enema group. LianMengtang enema group was treated by retention enema with LianMengtang, and mesiglitazol oral group was treated by mesiglitazol alone, three weeks as a course of treatment, and a course of treatment was observed. The clinical symptoms, TCM symptom score, 24 H ambulatory electrocardiogram (24 H) ventricular premature rate and curative effect were observed in the two groups. Results: 1. In improving the clinical symptoms of traditional Chinese medicine, the two groups can improve the clinical symptoms of Chinese medicine after treatment, LianMengtang enema group and mesiglitazol oral group have significant difference (p0.05), LianMengtang enema group is better than methyclol oral group; 2. In terms of the effect of ventricular premature beat, both groups could reduce the frequency of ventricular premature beat after treatment. There was no significant difference between LianMengtang enema group and mexilol oral group (p0.05), and the curative effect of LianMengtang enema group was similar to that of mesiglitazol oral group. Conclusion: 1. Mengtang enema treatment of phlegm and blood stasis obstruction of ventricular premature beats has a significant effect, can improve the clinical symptoms of patients, improve the quality of life of patients. 2. Mengtang enema can reduce the frequency of ventricular premature beats.
【學(xué)位授予單位】:黑龍江省中醫(yī)藥科學(xué)院
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R259
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 王杰;;黃連的藥效及臨床應(yīng)用[J];現(xiàn)代養(yǎng)生;2017年02期
2 張小艷;熊鵬;樊亞];胡勤輝;賴強(qiáng)華;王招玲;;針灸內(nèi)關(guān)、靈道及曲澤穴治療心律失常的臨床研究[J];實(shí)用中西醫(yī)結(jié)合臨床;2016年11期
3 韋麗蘭;;溫針灸配合穴位貼敷治療36例心脾兩虛型心悸的臨床觀察[J];中國(guó)民族民間醫(yī)藥;2016年19期
4 張軍;楊濤;郭琪;王沛雅;楊暉;;瀕危藥用植物羌活的研究進(jìn)展[J];安徽農(nóng)業(yè)科學(xué);2016年15期
5 張?zhí)照?榮巍巍;李清;畢開順;;遠(yuǎn)志的研究進(jìn)展[J];中草藥;2016年13期
6 梅雪;余劉勤;陳小云;周春陽(yáng);;何首烏化學(xué)成分和藥理作用的研究進(jìn)展[J];藥物評(píng)價(jià)研究;2016年01期
7 商麗麗;秦鵬;;針刺心包經(jīng)為主治療心律失常臨床療效觀察[J];四川中醫(yī);2016年01期
8 邊凌云;趙鵬飛;;孫霈教授辨證論治心悸經(jīng)驗(yàn)擷菁[J];中醫(yī)學(xué)報(bào);2015年07期
9 劉艷;呂延杰;楊寶峰;;M_3受體作為防治心血管疾病新靶點(diǎn)的研究進(jìn)展[J];藥學(xué)學(xué)報(bào);2015年04期
10 劉歡;李東文;李德新;;李德新教授治療心悸經(jīng)驗(yàn)總結(jié)[J];遼寧中醫(yī)藥大學(xué)學(xué)報(bào);2015年03期
,本文編號(hào):2415520
本文鏈接:http://sikaile.net/zhongyixuelunwen/2415520.html